IL136137A0 - Hydrophobically-modified protein compositions and methods - Google Patents

Hydrophobically-modified protein compositions and methods

Info

Publication number
IL136137A0
IL136137A0 IL13613798A IL13613798A IL136137A0 IL 136137 A0 IL136137 A0 IL 136137A0 IL 13613798 A IL13613798 A IL 13613798A IL 13613798 A IL13613798 A IL 13613798A IL 136137 A0 IL136137 A0 IL 136137A0
Authority
IL
Israel
Prior art keywords
protein
hydrophobically
methods
hydrophobic moiety
modified protein
Prior art date
Application number
IL13613798A
Other languages
English (en)
Original Assignee
Biogen Inc
Ontogeny Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Ontogeny Inc filed Critical Biogen Inc
Publication of IL136137A0 publication Critical patent/IL136137A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL13613798A 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods IL136137A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods

Publications (1)

Publication Number Publication Date
IL136137A0 true IL136137A0 (en) 2001-05-20

Family

ID=27490628

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13613798A IL136137A0 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Country Status (26)

Country Link
US (1) US6444793B1 (da)
EP (1) EP1036092B1 (da)
JP (1) JP4289788B2 (da)
KR (1) KR20010032753A (da)
CN (1) CN1294595A (da)
AT (1) ATE295372T1 (da)
AU (1) AU757497B2 (da)
BR (1) BR9815142A (da)
CA (1) CA2309806A1 (da)
CZ (1) CZ20002008A3 (da)
DE (1) DE69830192T2 (da)
DK (1) DK1036092T3 (da)
EA (1) EA003739B1 (da)
EE (1) EE200000308A (da)
ES (1) ES2243018T3 (da)
HK (1) HK1030953A1 (da)
HU (1) HUP0100535A3 (da)
IL (2) IL136137A0 (da)
IS (1) IS2163B (da)
MX (1) MXPA00005494A (da)
NO (1) NO20002789L (da)
NZ (1) NZ504752A (da)
PL (1) PL197833B1 (da)
PT (1) PT1036092E (da)
TR (1) TR200001612T2 (da)
WO (1) WO1999028343A2 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001525341A (ja) * 1997-11-28 2001-12-11 ロッシュ ディアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性ヘッジホッグタンパク質変異体、その調製方法及び医薬への適用
PT1036092E (pt) 1997-12-03 2005-09-30 Biogen Inc Compos~icoes e metodos de proteinas hidrofobicamente modificadas
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
ES2252886T3 (es) * 1998-04-30 2006-05-16 Curis, Inc. Conjugado de proteinas de erizo activo, proceso para su produccion y uso.
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
DE69939327D1 (de) * 1998-11-02 2008-09-25 Curis Inc Funktionelle antagonisten von hedgehog-aktivität
DE69931390T2 (de) * 1998-12-03 2007-06-06 Curis, Inc., Cambridge Verfahren und Zusammensetzungen zur Behandlung von Krankheiten bei denen Excitotoxizität beteiligt ist
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
IL149202A0 (en) * 1999-11-05 2002-11-10 Biogen Inc Hedgehog fusion proteins and uses
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
US7052514B2 (en) * 2000-04-28 2006-05-30 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
US20030235851A1 (en) * 2002-04-19 2003-12-25 Roberts Richard W. Methods of using sense and/or nonsense suppression to make nucleic acid-peptide display libraries containing peptides with unnatural amino acid residues
JP2008506703A (ja) 2004-07-14 2008-03-06 ユニバーシティ オブ ユタ リサーチ ファウンデーション ネトリン関連化合物および用途
WO2006101273A1 (ja) * 2005-03-25 2006-09-28 Takeda Pharmaceutical Company Limited 癌の予防・治療剤
RU2420580C2 (ru) * 2005-11-11 2011-06-10 Протеоджен Био С.Р.Л. Способ преобразования водорастворимых активных белков в гидрофобные активные белки, их применение для получения мономолекулярных слоев ориентированных активных белков и устройства, включающие водорастворимые активные белки, преобразованные в гидрофобные активные белки
WO2008057468A1 (en) 2006-11-02 2008-05-15 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
WO2009105783A1 (en) * 2008-02-21 2009-08-27 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of mntf peptides
WO2009108868A2 (en) * 2008-02-27 2009-09-03 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924754B (zh) * 2015-12-30 2021-11-09 北京大学 聚氨基酸偶联物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
MX2020004338A (es) 2017-10-25 2020-10-14 Janssen Pharmaceuticals Inc Composiciones de peptidos tau fosforilados y sus usos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
JP2002503088A (ja) * 1996-10-07 2002-01-29 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 新規ヘッジホッグ由来ポリペプチド
PT1036092E (pt) 1997-12-03 2005-09-30 Biogen Inc Compos~icoes e metodos de proteinas hidrofobicamente modificadas

Also Published As

Publication number Publication date
WO1999028343A9 (en) 1999-10-14
PT1036092E (pt) 2005-09-30
CZ20002008A3 (cs) 2001-11-14
JP2001525336A (ja) 2001-12-11
WO1999028343A2 (en) 1999-06-10
ATE295372T1 (de) 2005-05-15
BR9815142A (pt) 2000-10-10
JP4289788B2 (ja) 2009-07-01
DK1036092T3 (da) 2005-08-15
HUP0100535A2 (hu) 2001-06-28
EP1036092B1 (en) 2005-05-11
IL136137A (en) 2009-09-22
CA2309806A1 (en) 1999-06-10
WO1999028343A3 (en) 1999-08-12
AU757497B2 (en) 2003-02-20
PL341430A1 (en) 2001-04-09
HK1030953A1 (en) 2001-05-25
CN1294595A (zh) 2001-05-09
DE69830192T2 (de) 2006-01-12
EP1036092A2 (en) 2000-09-20
NO20002789L (no) 2000-08-02
US6444793B1 (en) 2002-09-03
HUP0100535A3 (en) 2003-09-29
IS2163B (is) 2006-11-15
ES2243018T3 (es) 2005-11-16
MXPA00005494A (es) 2003-05-19
NZ504752A (en) 2002-10-25
EE200000308A (et) 2001-10-15
AU1996699A (en) 1999-06-16
IS5499A (is) 2000-05-15
NO20002789D0 (no) 2000-05-31
PL197833B1 (pl) 2008-04-30
KR20010032753A (ko) 2001-04-25
EA200000605A1 (ru) 2000-12-25
TR200001612T2 (tr) 2001-01-22
EA003739B1 (ru) 2003-08-28
DE69830192D1 (de) 2005-06-16

Similar Documents

Publication Publication Date Title
HK1030953A1 (en) Hydrophobically-modified hedgehog protein compositions and methods.
De Caro et al. Porcine pancreatic lipase. Completion of the primary structure
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
AU4981101A (en) Subtilisin variants
CA2301046A1 (en) 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
WO1999006557A3 (en) Mammalian cell membrane proteins; related reagents
KR880701778A (ko) 펩티드의 합성 및 분리를 위한 효소막법
WO1999028876A3 (en) Hydrophobically-modified protein compositions and methods
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
WO1999022005A3 (en) Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2001096593A3 (en) Novel motor proteins and methods for their use
AU2001235894A1 (en) Novel mammalian secreted group iii phospholipase a2
AU7786198A (en) (chlamydia trachomatis) specific peptides and their use in diagnostic assays
WO2000034335A3 (en) 'death domain' containing receptors
BR0213772A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
WO2001025430A3 (en) Novel human membrane proteins
WO2000032746A3 (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
WO2001098314A3 (en) Novel motor proteins and methods for their use
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок